BEN-101 / Bennu Biotherap - LARVOL DELTA

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=16 | Recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting ➔ Recruiting | Trial completion date: Jun 2026 ➔ Jun 2027 | Trial primary completion date: Feb 2026 ➔ Feb 2027

Enrollment open • Metastases • Trial completion date • Trial primary completion date • Oncology • Solid Tumor

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=16 | Not yet recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Metastases • New P1 trial • Oncology • Solid Tumor